Friday, September 04, 2020 3:07:19 AM
It could be one of his enemies?
There are a number of people who tried to buy .005 shares who were rejected by kw and now have a vendetta against him.
More likely one of those.
Sell some cheaply bought .011 shares on the day the ind is announced to make it look as if the company is desperate and create the impression that sp only goes down on news.
Then claim it’s a pump and dump when it’s actually the manipulators sabotaging the share price.
Those sellers have wasted their shares yesterday imho.
Kw has raised enough cash to get the trial started.
Remember that Pharmacyte will only pay for 50 of the trial patients.
And if results are excellent after the first ten or so this could go straight to breakthrough.
And results will be in within weeks of the first Patients receiving the treatment.
The canine trials suggest it will be very impressive indeed?
We all know how this has been manipulated but those people will stand no chance against an fda approval and outstanding trial results.
We all know this isn’t mythical.
We all know where the smell emanates.
There are a number of people who tried to buy .005 shares who were rejected by kw and now have a vendetta against him.
More likely one of those.
Sell some cheaply bought .011 shares on the day the ind is announced to make it look as if the company is desperate and create the impression that sp only goes down on news.
Then claim it’s a pump and dump when it’s actually the manipulators sabotaging the share price.
Those sellers have wasted their shares yesterday imho.
Kw has raised enough cash to get the trial started.
Remember that Pharmacyte will only pay for 50 of the trial patients.
And if results are excellent after the first ten or so this could go straight to breakthrough.
And results will be in within weeks of the first Patients receiving the treatment.
The canine trials suggest it will be very impressive indeed?
We all know how this has been manipulated but those people will stand no chance against an fda approval and outstanding trial results.
We all know this isn’t mythical.
We all know where the smell emanates.
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
